Nutraceutical Renews Ephedra Case In Utah Court; FDA To Respond By Jan. 18
This article was originally published in The Tan Sheet
Executive Summary
FDA did not provide advance notice and opportunity for public comment when it "created a new adulteration standard" in its 2004 final rule banning ephedra alkaloids in dietary supplements, Nutraceutical argues in a motion renewing its case against FDA